Improvement of C3A cell metabolism for usage in bioartificial liver support systems

Journal of Hepatology

Volumn 41, Issue 4, 2004, Pages 599-605

  Filippi, Céline ^a   Keatch, Steven A ^a   Rangar, Deepa ^a   Nelson, Leonard J ^a   Hayes, Peter C ^a   Plevris, John N ^a  

^a Chancellor's Building ^*  (United Kingdom)

Author keywords

Albumin; Bioartificial liver support system; Fulminant hepatic failure; Galactose elimination; Gluconeogenesis; Ureogenesis

Indexed keywords

ALBUMIN; COMPLEMENT COMPONENT C3A; GALACTOSE; UREA;

ANIMAL CELL; ARTICLE; ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; CELL LINE; CELL METABOLISM; CONTROLLED STUDY; GLUCONEOGENESIS; HUMAN; LIVER CELL; LIVER FAILURE; NONHUMAN; PRIORITY JOURNAL; SERUM; UREA CYCLE;

ALBUMINS; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA; GALACTOSE; GLUCONEOGENESIS; HEPATOBLASTOMA; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; LIVER, ARTIFICIAL; SWINE; TIME FACTORS; UREA;

EID: 4644263741     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.012     Document Type: Article

References (39)

1. Van Thiel D.H., Brems J., Nadir A., Idilman R., Colantoni A., Holt D., et al. Liver transplantation for fulminant hepatic failure. J Gastroenterol. 36:2001;1-4
2. Plevris J.N., Schina M., Hayes P.C. Review article: the management of acute liver failure. Aliment Pharmacol Ther. 12:1998;405-418
3. Morsiani E., Pazzi P., Puviani A.C., Brogli M., Valieri L., Gorini P., et al. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs. 25:2002;192-202
4. Samuel D., Ichai P., Feray C., Saliba F., Azoulay D., Arulnaden J.L., et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation. 73:2002;257-264
5. Sussman N.L., Finegold M.J., Barish J.P., Kelly J.H. A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device. Am J Gastroenterol. 89:1994;1077-1082
6. Ellis A.J., Hughes R.D., Wendon J.A., Dunne J., Langley P.G., Kelly J.H., et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 24:1996;1446-1451
7. Watanabe F.D., Mullon C.J., Hewitt W.R., Arkadopoulos N., Kahaku E., Eguchi S., et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg. 225:1997;484-491
8. Chen S.C., Mullon C., Kahaku E., Watanabe F., Hewitt W., Eguchi S., et al. Treatment of severe liver failure with a bioartificial liver. Ann NY Acad Sci. 831:1997;350-360
9. Hayes P.C., Lee A. What progress with artificial livers? Lancet. 358:2001;1286-1287
10. Tsiaoussis J., Newsome P.N., Nelson L.J., Hayes P.C., Plevris J.N. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl. 7:2001;2-10
11. Nyberg S.L., Hibbs J.R., Hardin J.A., Germer J.J., Platt J.L., Paya C.V., et al. Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes. Liver Transpl. 6:2000;76-84
12. Wang L., Sun J., Li L., Mears D., Horvat M., Sheil A.G. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transpl. 7:1998;459-468
13. Khalil M., Shariat-Panahi A., Tootle R., Ryder T., McCloskey P., Roberts E., et al. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J Hepatol. 34:2001;68-77
14. Hughes R.D., Nicolaou N., Langley P.G., Ellis A.J., Wendon J.A., Williams R. Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. Artif Organs. 22:1998;854-858
15. Sosef M.N., Abrahamse L.S., van de Kerkhove M.P., Hartman R., Chamuleau R.A., van Gulik T.M. Assessment of the AMC-bioartificial liver in the anhepatic pig. Transplantation. 73:2002;204-209
16. Ong J.P., Aggarwal A., Krieger D., Easley K.A., Karafa M.T., Van Lente F., et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 114:2003;188-193
17. Walsh T.S., McLellan S., Mackenzie S.J., Lee A. Hyperlactatemia and pulmonary lactate production in patients with fulminant hepatic failure. Chest. 116:1999;471-476
18. Murphy N.D., Kodakat S.K., Wendon J.A., Jooste C.A., Muiesan P., Rela M., et al. Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med. 29:2001;2111-2118
19. Shi Q., Gaylor J.D., Cousins R., Plevris J., Hayes P.C., Grant M.H. The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs. 22:1998;1023-1030
20. Newsome P.N., Humphreys K., Tsiaoussis J., Keun A., Dollinger M., Sethi T., et al. Serum from patients with acute liver failure decreases cellular adhesion prior to inducing apoptotic cell death; important implications for hepatocyte transplantation. Hepatology. 34:2002;297A
21. Nelson L.J., Newsome P.N., Howie A.F., Hadoke P.W., Dabos K.J., Walker S.W., et al. An improved ex vivo method of primary porcine hepatocyte isolation for use in bioartificial liver systems. Eur J Gastroenterol Hepatol. 12:2000;923-930
22. Bergmeyer H. Methods of enzymatic analysis. 1974;Academic Press, London
23. Kessler M.A., Meinitzer A., Wolfbeis O.S. Albumin blue 580 fluorescence assay for albumin. Anal Biochem. 248:1997;180-182
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254
25. Lazar A., Mann H.J., Remmel R.P., Shatford R.A., Cerra F.B., Hu W.S. Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel. In Vitro Cell Dev Biol Anim. 31:1995;340-346
26. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. Fed Am Soc Exp Biol J. 13:1999;1883-1900
27. Bhandari R.N., Riccalton L.A., Lewis A.L., Fry J.R., Hammond A.H., Tendler S.J., et al. Liver tissue engineering: a role for co-culture systems in modifying hepatocyte function and viability. Tissue Eng. 7:2001;345-357
28. Dich J., Vind C., Grunnet N. Long-term culture of hepatocytes: ethanol oxidation and effect of ethanol on enzyme activities and albumin secretion. Alcohol Alcohol. Suppl 1:1987;271-275
29. Dich J., Vind C., Grunnet N. Long-term culture of hepatocytes: effect of hormones on enzyme activities and metabolic capacity. Hepatology. 8:1988;39-45
30. Weber K., Ridderskamp D., Alfert M., Hoyer S., Wiesner R.J. Cultivation in glucose-deprived medium stimulates mitochondrial biogenesis and oxidative metabolism in HepG2 hepatoma cells. Biol Chem. 383:2002;283-290
31. Rossignol R., Gilkerson R., Aggeler R., Yamagata K., Remington S.J., Capaldi R.A. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64:2004;985-993
32. Enosawa S., Suzuki S., Kakefuda T., Amemiya H. Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. Cell Transpl. 5:1996;S39-S40
33. Zeilinger K., Sauer I.M., Pless G., Strobel C., Rudzitis J., Wang A., et al. Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions. Altern Lab Anim. 30:2002;525-538
34. Sekiyama K.D., Yoshiba M., Thomson A.W. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol. 98:1994;71-77
35. Blazka M.E., Wilmer J.L., Holladay S.D., Wilson R.E., Luster M.I. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 133:1995;43-52
36. Kitade H., Kanemaki T., Sakitani K., Inoue K., Matsui Y., Kamiya T., et al. Regulation of energy metabolism by interleukin-1beta, but not by interleukin-6, is mediated by nitric oxide in primary cultured rat hepatocytes. Biochim Biophys Acta. 1311:1996;20-26
37. Kelly JH. United States Patent No. 5,290,684; 1992.
38. Bernal W., Donaldson N., Wyncoll D., Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 359:2002;558-563
39. Clemmesen J.O., Larsen F.S., Kondrup J., Hansen B.A., Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 29:1999;648-653